Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes
暂无分享,去创建一个
Yan Zhang | Kang Xu | Juan Xu | Yongsheng Li | Xia Li | Jianping Lu | Juan Chen | Hong Chen | Yongsheng Li | Juan Xu | Xia Li | Yan Zhang | Jinwen Zhang | Zishan Wang | Xueying Zhao | Kang Xu | Yixue Li | Hong Chen | Jianping Lu | Juan Chen | Zishan Wang | Yixue Li | Jinwen Zhang | Xueying Zhao
[1] Jian Zhang,et al. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells , 2014, Tumor Biology.
[2] Eujin Lee,et al. Methionine sulfoxide reductase B3 deficiency inhibits cell growth through the activation of p53-p21 and p27 pathways. , 2014, Archives of biochemistry and biophysics.
[3] Aleix Prat Aparicio. Comprehensive molecular portraits of human breast tumours , 2012 .
[4] F. Berthold,et al. Identification of DEIN, a Novel Gene with High Expression Levels in Stage IVS Neuroblastoma , 2007, Molecular Cancer Research.
[5] W. Woodward,et al. MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer. , 2016, International journal of radiation oncology, biology, physics.
[6] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[7] Debra L Winkeljohn. Triple-negative breast cancer. , 2008, Clinical journal of oncology nursing.
[8] J.,et al. The New England Journal of Medicine , 2012 .
[9] Bing Shi,et al. TAM: A method for enrichment and depletion analysis of a microRNA category in a list of microRNAs , 2010, BMC Bioinformatics.
[10] L. Pusztai,et al. Gene expression profiling in breast cancer: classification, prognostication, and prediction , 2011, The Lancet.
[11] Z. Culig. Words of wisdom: Re: TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c. , 2014, European urology.
[12] Carlos Caldas,et al. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis , 2007, Nature Reviews Cancer.
[13] Andrea Sottoriva,et al. The shaping and functional consequences of the microRNA landscape in breast cancer , 2013, Nature.
[14] Adam A. Margolin,et al. Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas , 2013, Nature Genetics.
[15] J. Slingerland,et al. Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy , 2013, Nature Reviews Cancer.
[16] Frank Berthold,et al. Co-regulated expression of HAND2 and DEIN by a bidirectional promoter with asymmetrical activity in neuroblastoma , 2009, BMC Molecular Biology.
[17] Ning Liu,et al. Systematic analysis of lncRNA–miRNA–mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer , 2018, Journal of Translational Medicine.
[18] Christian Gieger,et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization , 2006, Nature Genetics.
[19] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Tao Xi,et al. STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer , 2016, Oncotarget.
[21] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[22] V. Gebski,et al. Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] M. Esteller. Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.
[24] E. Andrechek,et al. A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer , 2013, Breast Cancer Research.
[25] Jason I. Herschkowitz,et al. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts , 2013, Genome Biology.
[26] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[27] Martin Reczko,et al. DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs , 2012, Nucleic Acids Res..
[28] Goberdhan P Dimri,et al. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells , 2016, Oncotarget.
[29] S. Oesterreich,et al. Three-Dimensional Breast Cancer Models Mimic Hallmarks of Size-Induced Tumor Progression. , 2016, Cancer research.
[30] R. Bast,et al. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] Xia Li,et al. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes. , 2014, Human molecular genetics.
[32] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[33] M. Dowsett,et al. Changes in Expression of Genes Representing Key Biologic Processes after Neoadjuvant Chemotherapy in Breast Cancer, and Prognostic Implications in Residual Disease , 2016, Clinical Cancer Research.
[34] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..
[35] R. Bellazzi,et al. Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] M. Fernö,et al. Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up , 2010, Breast Cancer Research and Treatment.
[37] E. Izaurralde,et al. Towards a molecular understanding of microRNA-mediated gene silencing , 2015, Nature Reviews Genetics.
[38] Y. Miki,et al. Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion , 2014, Scientific Reports.
[39] Tingting Shao,et al. The mRNA related ceRNA–ceRNA landscape and significance across 20 major cancer types , 2015, Nucleic acids research.
[40] Jinpeng Rao,et al. Construction of implantation failure related lncRNA-mRNA network and identification of lncRNA biomarkers for predicting endometrial receptivity , 2018, International journal of biological sciences.
[41] B. Xiao,et al. [Differences in expression profiles of circular RNA between luminal breast cancer cells and normal breast cells]. , 2018, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.
[42] David B. Alexander,et al. The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis , 2001, Cell.
[43] Paul L. Roebuck,et al. TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer. , 2015, Cancer research.
[44] Junxia Chen,et al. Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma , 2016, Oncotarget.
[45] Michael T. McManus,et al. Gene silencing in mammals by small interfering RNAs , 2002, Nature Reviews Genetics.
[46] References , 1971 .
[47] X. Cui,et al. LncRNA‐Hh Strengthen Cancer Stem Cells Generation in Twist‐Positive Breast Cancer via Activation of Hedgehog Signaling Pathway , 2015, Stem cells.
[48] N. Campbell. Genetic association database , 2004, Nature Reviews Genetics.
[49] Stefan Wuchty,et al. Peeling the yeast protein network , 2005, Proteomics.
[50] A. Chinnaiyan,et al. The emergence of lncRNAs in cancer biology. , 2011, Cancer discovery.
[51] C. Perou,et al. Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch , 2011, Proceedings of the National Academy of Sciences.
[52] Panayiotis Tsanakas,et al. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts , 2015, Nucleic Acids Res..
[53] P. Brown,et al. Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry. , 2014, The Lancet. Oncology.
[54] Kouhei Akazawa,et al. Programs for calculating the statistical powers of detecting susceptibility genes in case–control studies based on multistage designs , 2009, Bioinform..
[55] Daniel Birnbaum,et al. Genome profiling of ERBB2-amplified breast cancers , 2010, BMC Cancer.
[56] E. Davidson. Emerging properties of animal gene regulatory networks , 2010, Nature.
[57] P. Reitsma,et al. Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner , 2013, Proceedings of the National Academy of Sciences.
[58] M. Hou,et al. MiR-182 promotes proliferation and invasion and elevates the HIF-1α-VEGF-A axis in breast cancer cells by targeting FBXW7. , 2016, American journal of cancer research.
[59] J. Forbes,et al. Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer , 2014, BMC Cancer.
[60] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.